
    
      This study was a double-blinded, multicenter, activity, and safety study of KX2-391 Ointment
      administered topically to the face or scalp of participants with actinic keratosis.

      The study consists of Screening, Treatment, Follow-up, and Recurrence Follow-up Periods.
      Eligible participants received 5 consecutive days of topical treatment, to be applied at the
      study site. Activity (lesion counts) and safety evaluations was performed.
    
  